IPO13 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:9670, HGNC:16853, IMP13, IPO13, KAP13, LGL2, MIM:610411, NM_014652, NP_055467, RANBP13, XM_024451069, XM_024451070, XP_024306837, XP_024306838, importin 13

Omim:OMIM:610411

Id:91ba846c-79e6-5053-8d2e-da55a76f382c

Hgnc:HGNC:16853

Entrez:9670

Ensembl:ENSG00000117408

Description:importin 13

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View IPO13's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with IPO13.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using IPO13.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for IPO13.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with IPO13.

Results found

Linked to

	Label	Description
	GSE179667 NVP-BEZ235 U-87MG Uppsala 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE235587 mitoxantrone KYSE-70 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236280 panobinostat 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE133749 BMPR2 overexpression endothelial cell 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 3 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128099 GSE128159 gemcitabine SUM159PT 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE197630 enzalutamide prostate gland 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE117620 resveratrol 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE204836 PP-3 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE57871 vorinostat HCT 116 1 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE179667 NVP-BEZ235 U-87MG Uppsala 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE235587 mitoxantrone KYSE-70 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE236280 panobinostat 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE133749 BMPR2 overexpression endothelial cell 0 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE119369 H10 inhibition 3 v 8 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE128099 GSE128159 gemcitabine SUM159PT 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE197630 enzalutamide prostate gland 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE117620 resveratrol 2 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE204836 PP-3 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE57871 vorinostat HCT 116 1 v 12 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.